XPC and colonic neoplasm: These results suggest that XPC, and thus GG-NER, is not active in the removal of oxaliplatin-DNA lesions in a subset of colon cancer cells and that oxaliplatin exhibits elevated cytotoxicity when GG-NER is not engaged.